Product Code: GVR-4-68039-179-7
Non-invasive Intracranial Pressure Monitoring Devices Market Growth & Trends:
The global non-invasive intracranial pressure monitoring devices market size is anticipated to reach USD 478.1 million by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2025 to 2030. Increasing incidences of neurological diseases, coupled with a subsequent rise in the number of surgical procedures to treat associated conditions, are driving the market.
Non-invasive intracranial pressure monitoring devices are used to measure the pressure within the skull caused by trauma or medical conditions, such as intracranial hypertension, hydrocephalus, subarachnoid hemorrhages, inflammatory diseases, and cerebrospinal space diseases. These devices help in monitoring the pressure, as increased Intracranial Pressure (ICP) can result in serious or life-threatening medical problems.
Moreover, the high incidence rate of traumatic brain injuries due to road accidents and sports incidents is anticipated to boost the demand for non-invasive intracranial pressure monitoring devices. For instance, globally, in 2020 alone, around 11 million individuals are estimated to be affected by Traumatic Brain Injuries (TBIs).
Additionally, key players are adopting various strategies, such as M&A, partnerships, and product launches, to strengthen their foothold in the market. For instance, in November 2019, Raumedic AG introduced the ICP monitoring device for home use, which is intended for the diagnosis of people who suffer from hydrocephalus.
Non-invasive Intracranial Pressure Monitoring Devices Market Report Highlights:
- On the basis of type, the MRI/CT scan segment dominated the overall market with a share of 28.4% in 2024. These are robust imaging tools that can detect early signs of injuries, such as microhemorrhage, contusion, and hydrocephalus, due to their higher sensitivity unlike others
- Based on the application, The traumatic brain injury segment dominated the non-invasive intracranial pressure monitoring devices industry with the largest revenue share in 2024 owing to the increasing prevalence of TBI and high demand for ICP monitoring devices in trauma care centers
- North America dominated the market with the largest revenue share of 45.1% in 2024 owing to the high incidence of trauma cases and easy availability of technologically advanced healthcare infrastructure in the region
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Application
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Non-Invasive Intracranial Pressure Monitoring Device Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
Chapter 4. Non-Invasive Intracranial Pressure Monitoring Device Market: Type Business Analysis
- 4.1. Type Market Share, 2024 & 2030
- 4.2. Type Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 4.4. Transcranial Doppler Ultrasonography
- 4.4.1. Transcranial Doppler Ultrasonography Market, 2018 - 2030 (USD Million)
- 4.5. Tympanic Membrane Displacement (TMD)
- 4.5.1. Tympanic Membrane Displacement (TMD) Market, 2018 - 2030 (USD Million)
- 4.6. Optic Nerve Sheath Diameter
- 4.6.1. Optic Nerve Sheath Diameter Market, 2018 - 2030 (USD Million)
- 4.7. MRI/CT
- 4.7.1. MRI/CT Market, 2018 - 2030 (USD Million)
- 4.8. Fundoscopy (papilledema)
- 4.8.1. Fundoscopy (papilledema) Market, 2018 - 2030 (USD Million)
Chapter 5. Non-Invasive Intracranial Pressure Monitoring Device Market: Application Business Analysis
- 5.1. Application Market Share, 2024 & 2030
- 5.2. Application Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Traumatic Brain Injury
- 5.4.1. Traumatic Brain Injury Segment Market, 2018 - 2030 (USD Million)
- 5.5. Intracerebral Hemorrhage
- 5.5.1. Intracerebral Hemorrhage Segment Market, 2018 - 2030 (USD Million)
- 5.6. Meningitis
- 5.6.1. Meningitis Segment Market, 2018 - 2030 (USD Million)
- 5.7. Subarachnoid Hemorrhage
- 5.7.1. Subarachnoid Hemorrhage Segment Market, 2018 - 2030 (USD Million)
- 5.8. Others
- 5.8.1. Others Segment Market, 2018 - 2030 (USD Million)
Chapter 6. Non-Invasive Intracranial Pressure Monitoring Device Market: Regional Estimates & Trend Analysis
- 6.1. Regional Market Share Analysis, 2024 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 6.4. North America
- 6.4.1. North America Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.4.2. U.S.
- 6.4.2.1. Key Country Dynamics
- 6.4.2.2. Regulatory Framework
- 6.4.2.3. Competitive Insights
- 6.4.2.4. U.S. Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. Canada
- 6.4.3.1. Key Country Dynamics
- 6.4.3.2. Regulatory Framework
- 6.4.3.3. Competitive Insights
- 6.4.3.4. Canada Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.4. Mexico
- 6.4.4.1. Key Country Dynamics
- 6.4.4.2. Regulatory Framework
- 6.4.4.3. Competitive Insights
- 6.4.4.4. Mexico Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5. Europe
- 6.5.1. Europe Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.5.2. UK
- 6.5.2.1. Key Country Dynamics
- 6.5.2.2. Regulatory Framework
- 6.5.2.3. Competitive Insights
- 6.5.2.4. UK Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Germany
- 6.5.3.1. Key Country Dynamics
- 6.5.3.2. Regulatory Framework
- 6.5.3.3. Competitive Insights
- 6.5.3.4. Germany Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.4. France
- 6.5.4.1. Key Country Dynamics
- 6.5.4.2. Regulatory Framework
- 6.5.4.3. Competitive Insights
- 6.5.4.4. France Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.5. Italy
- 6.5.5.1. Key Country Dynamics
- 6.5.5.2. Regulatory Framework
- 6.5.5.3. Competitive Insights
- 6.5.5.4. Italy Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.6. Spain
- 6.5.6.1. Key Country Dynamics
- 6.5.6.2. Regulatory Framework
- 6.5.6.3. Competitive Insights
- 6.5.6.4. Spain Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.7. Denmark
- 6.5.7.1. Key Country Dynamics
- 6.5.7.2. Regulatory Framework
- 6.5.7.3. Competitive Insights
- 6.5.7.4. Denmark Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.8. Sweden
- 6.5.8.1. Key Country Dynamics
- 6.5.8.2. Regulatory Framework
- 6.5.8.3. Competitive Insights
- 6.5.8.4. Sweden Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.9. Norway
- 6.5.9.1. Key Country Dynamics
- 6.5.9.2. Regulatory Framework
- 6.5.9.3. Competitive Insights
- 6.5.9.4. Norway Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6. Asia Pacific
- 6.6.1. Asia Pacific Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.6.2. Japan
- 6.6.2.1. Key Country Dynamics
- 6.6.2.2. Regulatory Framework
- 6.6.2.3. Competitive Insights
- 6.6.2.4. Japan Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. China
- 6.6.3.1. Key Country Dynamics
- 6.6.3.2. Regulatory Framework
- 6.6.3.3. Competitive Insights
- 6.6.3.4. China Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. India
- 6.6.4.1. Key Country Dynamics
- 6.6.4.2. Regulatory Framework
- 6.6.4.3. Competitive Insights
- 6.6.4.4. India Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. Australia
- 6.6.5.1. Key Country Dynamics
- 6.6.5.2. Regulatory Framework
- 6.6.5.3. Competitive Insights
- 6.6.5.4. Australia Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.6. South Korea
- 6.6.6.1. Key Country Dynamics
- 6.6.6.2. Regulatory Framework
- 6.6.6.3. Competitive Insights
- 6.6.6.4. South Korea Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.7. Thailand
- 6.6.7.1. Key Country Dynamics
- 6.6.7.2. Regulatory Framework
- 6.6.7.3. Competitive Insights
- 6.6.7.4. Thailand Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.7. Latin America
- 6.7.1. Latin America Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.7.2. Brazil
- 6.7.2.1. Key Country Dynamics
- 6.7.2.2. Regulatory Framework
- 6.7.2.3. Competitive Insights
- 6.7.2.4. Brazil Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.7.3. Argentina
- 6.7.3.1. Key Country Dynamics
- 6.7.3.2. Regulatory Framework
- 6.7.3.3. Competitive Insights
- 6.7.3.4. Argentina Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.8. MEA
- 6.8.1. MEA Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.8.2. South Africa
- 6.8.2.1. Key Country Dynamics
- 6.8.2.2. Regulatory Framework
- 6.8.2.3. Competitive Insights
- 6.8.2.4. South Africa Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.8.3. Saudi Arabia
- 6.8.3.1. Key Country Dynamics
- 6.8.3.2. Regulatory Framework
- 6.8.3.3. Competitive Insights
- 6.8.3.4. Saudi Arabia Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.8.4. UAE
- 6.8.4.1. Key Country Dynamics
- 6.8.4.2. Regulatory Framework
- 6.8.4.3. Competitive Insights
- 6.8.4.4. UAE Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.8.5. Kuwait
- 6.8.5.1. Key Country Dynamics
- 6.8.5.2. Regulatory Framework
- 6.8.5.3. Competitive Insights
- 6.8.5.4. Kuwait Non-Invasive Intracranial Pressure Monitoring Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Participant Overview
- 7.2. Company Market Position Analysis
- 7.3. Company Categorization
- 7.4. Strategy Mapping
- 7.5. Company Profiles/Listing
- 7.5.1. Medtronic
- 7.5.1.1. Overview
- 7.5.1.2. Financial Performance
- 7.5.1.3. Product Benchmarking
- 7.5.1.4. Strategic Initiatives
- 7.5.2. Integra LifeSciences Corporation
- 7.5.2.1. Overview
- 7.5.2.2. Financial Performance
- 7.5.2.3. Product Benchmarking
- 7.5.2.4. Strategic Initiatives
- 7.5.3. Spiegelberg GmbH & Co. KG
- 7.5.3.1. Overview
- 7.5.3.2. Financial Performance
- 7.5.3.3. Product Benchmarking
- 7.5.3.4. Strategic Initiatives
- 7.5.4. RAUMEDIC AG
- 7.5.4.1. Overview
- 7.5.4.2. Financial Performance
- 7.5.4.3. Product Benchmarking
- 7.5.4.4. Strategic Initiatives
- 7.5.5. Vittamed
- 7.5.5.1. Overview
- 7.5.5.2. Financial Performance
- 7.5.5.3. Product Benchmarking
- 7.5.5.4. Strategic Initiatives
- 7.5.6. Gaeltec Devices Ltd.
- 7.5.6.1. Overview
- 7.5.6.2. Financial Performance
- 7.5.6.3. Product Benchmarking
- 7.5.6.4. Strategic Initiatives
- 7.5.7. HeadSense Medical
- 7.5.7.1. Overview
- 7.5.7.2. Financial Performance
- 7.5.7.3. Product Benchmarking
- 7.5.7.4. Strategic Initiatives
- 7.5.8. NeuroDx Development
- 7.5.8.1. Overview
- 7.5.8.2. Financial Performance
- 7.5.8.3. Product Benchmarking
- 7.5.8.4. Strategic Initiatives
- 7.5.9. Sophysa
- 7.5.9.1. Overview
- 7.5.9.2. Financial Performance
- 7.5.9.3. Product Benchmarking
- 7.5.9.4. Strategic Initiatives